Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas L Burkard

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Viruses|May 31, 2019
Hepatitis E Virus Drug DevelopmentVolker Kinast, Thomas L Burkard, Daniel Todt, et al.
Hepatology (Baltimore, Md.)|February 6, 2023
EGF receptor modulates HEV entry in human hepatocytesJil A Schrader, Thomas L Burkard, Yannick Brüggemann, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 9, 2025
Mycophenolic acid treatment drives the emergence of novel SARS-CoV-2 variantsToni Luise Meister, Maximilian K Nocke, Natalie Heinen, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Viruses|May 31, 2019
Hepatitis E Virus Drug DevelopmentVolker Kinast, Thomas L Burkard, Daniel Todt, et al.
Hepatology (Baltimore, Md.)|February 6, 2023
EGF receptor modulates HEV entry in human hepatocytesJil A Schrader, Thomas L Burkard, Yannick Brüggemann, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 9, 2025
Mycophenolic acid treatment drives the emergence of novel SARS-CoV-2 variantsToni Luise Meister, Maximilian K Nocke, Natalie Heinen, et al.
Pageof 1